Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials

BACKGROUND: Two phase III trials, ECZTRA 1 and 2, confirmed the efficacy and safety of tralokinumab versus placebo in adults with moderate-to-severe atopic dermatitis (AD). To further explore the long-term efficacy of tralokinumab for AD, a pooled analysis of these trials was conducted. METHODS: ECZ...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Eric L., Pink, Andrew E., Blauvelt, Andrew, Gooderham, Melinda, Armstrong, April W., Worm, Margitta, Katoh, Norito, Peris, Ketty, Puig, Luis, Barbarot, Sébastien, Mark, Thomas, Steffensen, Louise Abildgaard, Tindberg, Ann-Marie, Wollenberg, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570233/
https://www.ncbi.nlm.nih.gov/pubmed/37682422
http://dx.doi.org/10.1007/s40257-023-00806-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570233/
https://www.ncbi.nlm.nih.gov/pubmed/37682422
http://dx.doi.org/10.1007/s40257-023-00806-3

Ejemplares similares